Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-01-19

FDA Approved: PAROXETINE — Supplemental Application (NorthStar Rx LLC)

View source ↗

Summary

The FDA granted a supplemental approval for paroxetine hydrochloride (paroxetine) from NorthStar Rx LLC under an ANDA. This approval confirms regulatory clearan…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Paroxetine (Paroxetine hydrochloride)

Snippet

SUPPL AP for PAROXETINE (PAROXETINE HYDROCHLORIDE)